Format

Send to

Choose Destination
Cell Biol Int. 2007 Aug;31(8):851-5. Epub 2007 Feb 28.

Transforming growth factor beta-1 enhances cytotoxic effect of doxorubicin in human lung adenocarcinoma cells of A549 line.

Author information

1
Department of Regulation of Cell Proliferation, Institute of Cell Biology NAS of Ukraine, Drahomanova Street 14-16, 79005 Lviv, Ukraine.

Abstract

Transforming growth factor beta-1 (TGFbeta-1) is a regulator of cell proliferation, differentiation and apoptosis. Doxorubicin (adriamycin), an anthracycline drug causing double-strand DNA breaks, is widely used in anticancer chemotherapy. Here we demonstrated that TGFbeta-1 enhanced cytotoxic (proapoptotic) action of doxorubicin towards cultured human lung carcinoma A549 cells. Western-blot analysis and immunocytochemistry were used to show that doxorubicin induced PARP degradation in A549 cells, and TGFbeta-1 enhanced that action of the drug. The obtained results suggest a possibility of biomodulating effect of TGFbeta-1 on tumor cell treatment with doxorubicin.

PMID:
17418594
DOI:
10.1016/j.cellbi.2007.02.008
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center